Nasopharyngeal Carcinoma Clinical Trials in Zhuhai, Guangdong
10 recruitingZhuhai, Guangdong, China
Showing 1–10 of 10 trials
Recruiting
Phase 3
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Ming-Yuan Chen346 enrolled15 locationsNCT07328854
Recruiting
Phase 2
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen208 enrolled6 locationsNCT07070479
Recruiting
Not Applicable
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas
ScreeningNasopharyngeal Carcinoma (NPC)Epstein Barr Virus
Ming-Yuan Chen68,649 enrolled1 locationNCT06870435
Recruiting
Phase 2
Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen32 enrolled1 locationNCT06472713
Recruiting
Not Applicable
Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma
SurgeryRadiotherapyNasopharyngeal Carcinoma
Ming-Yuan Chen86 enrolled2 locationsNCT06688760
Recruiting
Phase 3
Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.
Nasopharyngeal CarcinomaDe-escalation Therapy
Sun Yat-sen University586 enrolled1 locationNCT06675214
Recruiting
Not Applicable
Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.
Nasopharyngeal Carcinoma
Ming-Yuan Chen384 enrolled1 locationNCT06529562
Recruiting
Not Applicable
Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.
SurgeryNasopharyngeal CarcinomaIntensity Modulated Radiotherapy
Sun Yat-sen University442 enrolled1 locationNCT06533267
Recruiting
Phase 2
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma
RadiotherapyCapecitabinePD-1 Inhibitor+1 more
Fifth Affiliated Hospital, Sun Yat-Sen University28 enrolled1 locationNCT05290194
Recruiting
Phase 3
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Carcinoma+1 more
Sun Yat-sen University226 enrolled6 locationsNCT04453813